NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,037 | -2.0% | 24,867 | +0.6% | 0.00% | – |
| Q2 2023 | $183,647 | -68.3% | 24,717 | -70.4% | 0.00% | -100.0% |
| Q1 2023 | $579,438 | -32.6% | 83,613 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $859,542 | -44.3% | 83,613 | -1.4% | 0.00% | -50.0% |
| Q3 2022 | $1,544,000 | -64.6% | 84,813 | 0.0% | 0.00% | -63.6% |
| Q2 2022 | $4,362,000 | -36.1% | 84,813 | -8.5% | 0.01% | -15.4% |
| Q1 2022 | $6,829,000 | -48.9% | 92,716 | -0.7% | 0.01% | -45.8% |
| Q4 2021 | $13,364,000 | -30.7% | 93,411 | +0.4% | 0.02% | -36.8% |
| Q3 2021 | $19,289,000 | -5.0% | 93,042 | -2.7% | 0.04% | 0.0% |
| Q2 2021 | $20,303,000 | +378.1% | 95,628 | +308.2% | 0.04% | +375.0% |
| Q1 2021 | $4,247,000 | +49.3% | 23,426 | -8.2% | 0.01% | +33.3% |
| Q4 2020 | $2,845,000 | -7.7% | 25,516 | -10.3% | 0.01% | -14.3% |
| Q3 2020 | $3,083,000 | +45.7% | 28,456 | +12.1% | 0.01% | +40.0% |
| Q2 2020 | $2,116,000 | – | 25,386 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $18,549,000 | 4.18% |
| OPTIMAS CAPITAL Ltd | 27,800 | $2,047,000 | 1.92% |
| RA Capital Management | 692,794 | $51,024,000 | 1.11% |
| Mendel Capital Management LLC | 13,689 | $1,008,000 | 0.95% |
| Rock Springs Capital Management LP | 448,200 | $33,010,000 | 0.83% |
| SECTORAL ASSET MANAGEMENT INC | 50,500 | $3,719,000 | 0.66% |
| TOBAM | 173,685 | $12,792,000 | 0.64% |
| SECTOR GAMMA AS | 38,324 | $2,823,000 | 0.61% |
| HAP Trading, LLC | 212,100 | $12,723,000 | 0.53% |
| Parametrica Management Ltd | 9,539 | $703,000 | 0.52% |